Souhaitez-vous accéder aux communiqués récents ?

NNIT A/S today announces that Claus Rydkjær has been appointed Chief Executive Officer, joining the company as of April 7, 2026. Claus Rydkjær will succeed Pär Fors, who in January announced his...

Transparantieverklaring vanBank of America Corporation In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen, werd Umicore...

Déclaration de transparence parBank of America Corporation Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a récemment été...

Transparency notification byBank of America Corporation In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by Bank of...

Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding a publication relating to a...

미국 캘리포니아주 랜초 코르도바, March 18, 2026 (GLOBE NEWSWIRE) -- SK 팜테코 (SK pharmteco)가 미국 텍사스주 라포트(La Porte)에 위치한 북미 소분자 생산시설에 대한 규제 당국의 실사가 성공적으로 마무리됐다고 오늘 발표했다. 미국 식품의약국(FDA)은 2026년 2월 9일부터 2월 12일까지 해당 시설에...

RANCHO CORDOVA, Kalifornien, March 17, 2026 (GLOBE NEWSWIRE) -- SK pharmteco gab heute den erfolgreichen Abschluss einer behördlichen Inspektion seiner nordamerikanischen Produktionsstätte für...

RANCHO CORDOVA, Californie, 17 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui l’issue favorable de l’inspection réglementaire de son site de petites molécules en Amérique du Nord,...

Eik fasteignafélag efnir til útboðs á skuldabréfum miðvikudaginn 25. mars 2026. Boðinn verður til sölu nýr skuldabréfaflokkur EIK 150531. Skuldabréfaflokkurinn EIK 150531 er verðtryggður flokkur með...

SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas.